Menu
GeneBe

rs11552507

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000289.6(PFKM):c.306C>T(p.Ala102=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0223 in 1,614,122 control chromosomes in the GnomAD database, including 491 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 32 hom., cov: 32)
Exomes 𝑓: 0.023 ( 459 hom. )

Consequence

PFKM
NM_000289.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.338
Variant links:
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 12-48132936-C-T is Benign according to our data. Variant chr12-48132936-C-T is described in ClinVar as [Benign]. Clinvar id is 255761.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-48132936-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0189 (2871/152270) while in subpopulation NFE AF= 0.0289 (1963/68014). AF 95% confidence interval is 0.0278. There are 32 homozygotes in gnomad4. There are 1402 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PFKMNM_000289.6 linkuse as main transcriptc.306C>T p.Ala102= synonymous_variant 5/23 ENST00000359794.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PFKMENST00000359794.11 linkuse as main transcriptc.306C>T p.Ala102= synonymous_variant 5/231 NM_000289.6 P1P08237-1

Frequencies

GnomAD3 genomes
AF:
0.0189
AC:
2872
AN:
152152
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00355
Gnomad AMI
AF:
0.0452
Gnomad AMR
AF:
0.0129
Gnomad ASJ
AF:
0.0334
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.0316
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0289
Gnomad OTH
AF:
0.0182
GnomAD3 exomes
AF:
0.0196
AC:
4916
AN:
251300
Hom.:
65
AF XY:
0.0192
AC XY:
2605
AN XY:
135800
show subpopulations
Gnomad AFR exome
AF:
0.00351
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.0387
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.00451
Gnomad FIN exome
AF:
0.0297
Gnomad NFE exome
AF:
0.0281
Gnomad OTH exome
AF:
0.0225
GnomAD4 exome
AF:
0.0227
AC:
33178
AN:
1461852
Hom.:
459
Cov.:
34
AF XY:
0.0224
AC XY:
16265
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00338
Gnomad4 AMR exome
AF:
0.0102
Gnomad4 ASJ exome
AF:
0.0369
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00466
Gnomad4 FIN exome
AF:
0.0309
Gnomad4 NFE exome
AF:
0.0256
Gnomad4 OTH exome
AF:
0.0178
GnomAD4 genome
AF:
0.0189
AC:
2871
AN:
152270
Hom.:
32
Cov.:
32
AF XY:
0.0188
AC XY:
1402
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00354
Gnomad4 AMR
AF:
0.0129
Gnomad4 ASJ
AF:
0.0334
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00477
Gnomad4 FIN
AF:
0.0316
Gnomad4 NFE
AF:
0.0289
Gnomad4 OTH
AF:
0.0180
Alfa
AF:
0.0261
Hom.:
31
Bravo
AF:
0.0165
Asia WGS
AF:
0.00231
AC:
9
AN:
3478
EpiCase
AF:
0.0261
EpiControl
AF:
0.0257

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease, type VII Benign:5
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 16, 2023- -
Benign, criteria provided, single submitterclinical testingPars Genome LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 24, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicMay 01, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
Cadd
Benign
10
Dann
Benign
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11552507; hg19: chr12-48526719; API